94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Zita Wachal1†Anna Szilágyi1†Barbara Takács1Adrienn Mónika Szabó1Dániel Priksz1Mariann Bombicz1Judit Szilvássy2Béla Juhász1Zoltán Szilvássy1‡
Balázs Varga1‡*- 1Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
- 2Department of Oto-Rhino-Laryngology and Head and Neck Surgery, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
A Corrigendum on
Improved survival and retinal function of aging ZDF rats in long-term, uncontrolled diabetes by BGP-15 treatment
by Wachal, Z., Szilágyi, A., Takács, B., Szabó, A. M., Priksz, D., Bombicz, M., Szilvássy, J., Juhász, B., Szilvássy, Z., and Varga, B. (2021). Front. Pharmacol. 12:650207. doi: 10.3389/fphar.2021.650207
In the published article, there was an error in affiliation 1. Instead of “Department of Pharmacology and Pharmacotherapy, University of Debrecen, Debrecen, Hungary”, it should be “Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, Debrecen, Hungary”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: diabetes, survival, ZDf, retinopathy, erg, BGP-15
Citation: Wachal Z, Szilágyi A, Takács B, Szabó AM, Priksz D, Bombicz M, Szilvássy J, Juhász B, Szilvássy Z and Varga B (2022) Corrigendum: Improved survival and retinal function of aging ZDF rats in long-term, uncontrolled diabetes by BGP-15 treatment. Front. Pharmacol. 13:1034389. doi: 10.3389/fphar.2022.1034389
Received: 01 September 2022; Accepted: 02 September 2022;
Published: 16 September 2022.
Approved by:
Frontiers in Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Wachal, Szilágyi, Takács, Szabó, Priksz, Bombicz, Szilvássy, Juhász, Szilvássy and Varga. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Balázs Varga, dmFyZ2EuYmFsYXpzQHBoYXJtLnVuaWRlYi5odQ==
†These authors have contributed equally to this work and share first authorship
‡These authors have contributed equally to this work and share last authorship